Company Performance: XVIVO Perfusion AB's financial health, profitability, and growth prospects significantly impact its stock price. Positive earnings reports and promising product developments tend to drive the price upward.

Market Sentiment: General investor optimism or pessimism towards the medical technology sector and the overall Swedish stock market (OMX Stockholm) can influence demand for XVIVO.ST shares.

Industry Trends: Developments in organ transplantation, such as advancements in preservation techniques or regulatory changes, can affect investor perceptions of XVIVO's long-term potential.

Competition: The presence of rival companies offering similar organ perfusion technologies and their respective market shares can impact XVIVO's competitive position and stock value.

Economic Factors: Macroeconomic variables like interest rates, inflation, and currency exchange rates in Sweden and globally can indirectly influence investor behavior and stock valuations.

Regulatory Environment: Changes in regulations related to medical devices, organ transplantation, or healthcare reimbursement policies can impact XVIVO's business operations and profitability.

Investor Perception of Risk: XVIVO is a smaller Swedish company. Risk aversion is a function of volatility and therefore influences stock price.